Condensed Consolidated Balance Sheets (Unaudited) (Parenthetical) - USD ($) $ in Millions	Mar. 31, 2024		Dec. 31, 2023
Investment securities, fair value	$ 1,618		$ 1,647
Investment securities, amortized cost basis	1,743		1,765
Net finance receivables	21,083		21,349
Financing receivable, allowance for credit loss	2,454		2,480
Restricted cash and restricted cash equivalents	599	[1]	534
Long-term debt	19,520		19,813
Other liabilities	$ 543		$ 671
Common stock, par value (in dollars per share)	$ 0.01		$ 0.01
Common stock, shares authorized (in shares)	2,000,000,000		2,000,000,000
Common stock, shares issued (in shares)	119,877,252		119,757,277
Common stock, shares outstanding (in shares)	119,877,252		119,757,277
Treasury stock at cost (in shares)	15,475,531		15,383,804
Consolidated VIEs
Net finance receivables	$ 12,641		$ 12,780
Financing receivable, allowance for credit loss	1,429		1,428
Restricted cash and restricted cash equivalents	576		523
Long-term debt	11,420		11,579
Other liabilities	$ 26		$ 26

[1] Restricted cash and restricted cash equivalents primarily represent funds required to be used for future debt payments relating to our secured transactions.